| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |